| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 667876 | Null | 0.00578566967432518 | 0.11440271 |
| NSC 708046 | Null | 0.00578566967432518 | 0.26490847 |
| NSC 70931 | 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- | 0.00578566967432518 | 0.37941339 |
| NSC 709362 | Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- | 0.00578566967432518 | 0.32478864 |
| NSC 716142 | Null | 0.00578566967432518 | -0.1101288 |
| NSC 33092 | Null | 0.00640068043275774 | 0.35639824 |
| NSC 730691 | Null | 0.00640068043275774 | 0.16306999 |
| NSC 735472 | (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol | 0.00640068043275774 | 0.3639381 |
| NSC 744023 | (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.00640068043275774 | 0.17161826 |
| NSC 686560 | [Di-17.alpha./.beta.-(2-ethoxy-3-hydroxyestra-1,3,5(10)-triene)-]sulphite | 0.00648124190744032 | 0.18380602 |